1-203165401-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000674.3(ADORA1):āc.482G>Cā(p.Ser161Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,611,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_000674.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADORA1 | NM_000674.3 | c.482G>C | p.Ser161Thr | missense_variant | 4/4 | ENST00000337894.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADORA1 | ENST00000337894.9 | c.482G>C | p.Ser161Thr | missense_variant | 4/4 | 2 | NM_000674.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000524 AC: 13AN: 248276Hom.: 0 AF XY: 0.0000298 AC XY: 4AN XY: 134032
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1458766Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 725428
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 22, 2023 | The c.482G>C (p.S161T) alteration is located in exon 4 (coding exon 2) of the ADORA1 gene. This alteration results from a G to C substitution at nucleotide position 482, causing the serine (S) at amino acid position 161 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at